Oncology and Regenerative Medicine Drive Japan's CRO Market
Oncology and regenerative medicine are the fastest-growing therapeutic areas in Japan's Contract Research Organization Market. Cancer remains a leading cause of mortality in Japan, and the country has invested heavily in cancer research, precision oncology, and advanced therapies. At the same time, Japan is a global leader in regenerative medicine, with a regulatory framework designed to...
0 Σχόλια 0 Μοιράστηκε 0 Προεπισκόπηση